Monuril (Fosfomycin Trometamol)

Fosfomycin Trometamol, the active ingredient in Monuril, is a phosphonic acid antibiotic presented as an oral tablet for systemic use. It treats uncomplicated urinary tract infections caused by susceptible bacteria, typically in adult women. The single‑dose regimen provides convenient therapy for acute infections.

GNH USA supplies Monuril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Monuril, a phosphonic acid antibiotic, is indicated for infections of the urinary tract.

Uncomplicated urinary tract infection (cystitis): achieves bacterial eradication and rapid symptom relief. Acute uncomplicated cystitis: provides a single‑dose treatment that clears infection in most patients. Suspected infection by fosfomycin‑susceptible uropathogens: offers broad‑spectrum coverage for first‑line therapy.

Fosfomycin Trometamol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Headache

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate medical attention. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions. - Clostridioides difficile‑associated colitis: may occur after antibiotic therapy.

Before prescribing Monuril, clinicians should consider several safety aspects. - Renal function assessment: evaluate kidney function before initiating therapy. - Pregnancy safety: avoid use unless benefits outweigh potential risks, as data are limited. - Breastfeeding: consider potential exposure to infant; use only if clearly needed. - Known hypersensitivity: do not administer to patients with documented fosfomycin allergy. - Concomitant medications: review for possible interactions that may affect efficacy. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Fosfomycin Trometamol can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: significantly reduce fosfomycin absorption. - Metoclopramide: may decrease oral bioavailability of fosfomycin. - Probenecid: can increase serum fosfomycin concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as fosfomycin may potentiate anticoagulant effect. - Oral contraceptives: possible reduction in efficacy; advise additional contraceptive measures. - Diuretics: monitor electrolyte balance and renal function during combined use.